🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Omada Health, Inc. (OMDA)
NASDAQ: OMDA · Real-Time Price · USD
11.87
-0.63 (-5.04%)
At close: Nov 20, 2026, 4:00 PM EST
11.81
-0.06 (-0.51%)
After-hours: Nov 20, 2026, 7:30 PM EST

Omada Health Stock Forecast

Stock Price Forecast

According to 12 analysts polled by S&P Global, Omada Health stock has a consensus rating of "Buy" and an average price target of $26.5. The average 1-year stock price forecast is 123.25% higher than the current stock price, while the lowest is $19 (+60.07%) and the highest is $35 (+194.86%).

Price Target: $26.5 (+123.25%)
Analyst Consensus: Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$19$26.5$25$35
Change+60.07%+123.25%+110.61%+194.86%

Analyst Ratings

The average analyst rating for Omada Health stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart
RatingMay '26Jul '26Aug '26Sep '26Oct '26Nov '26
Strong Buy555555
Buy555555
Hold222222
Sell000000
Strong Sell000000
Total121212121212

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
J.P. Morgan
J.P. Morgan
Buy
Maintains
$30 → $25
BuyMaintains$30 → $25+110.61%Nov 16, 2026
Morgan Stanley
Morgan Stanley
Buy
Reiterates
$30
BuyReiterates$30+152.74%Nov 9, 2026
Canaccord Genuity
Canaccord Genuity
Buy
Reiterates
$28
BuyReiterates$28+135.89%Nov 6, 2026
BMO Capital
BMO Capital
Buy
Maintains
$24
BuyMaintains$24+102.19%Nov 6, 2026
Wells Fargo
Wells Fargo
Hold
Maintains
$22 → $19
HoldMaintains$22 → $19+60.07%Nov 6, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
345.15M
from 260.21M
Increased by 32.64%
Revenue Next Year
411.81M
from 345.15M
Increased by 19.31%
EPS This Year
0.57
from 0.15
Increased by 268.42%
EPS Next Year
0.69
from 0.57
Increased by 21.07%
Fiscal YearFY 2022FY 2023FY 2024FY 2025FY 2026E
Period EndingDec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
89.19M122.78M169.80M260.21M345.15M
Revenue Growth
-37.67%38.29%53.25%32.64%
Gross Profit
42.79M69.97M102.88M170.94M253.51M
Gross Margin
47.98%56.99%60.59%65.69%73.45%
Operating Income
-72.35M-66.00M-43.65M-11.97M6.89M
Net Income
-72.52M-67.51M-47.14M-12.78M13.05M
EPS
---0.150.57
EPS Growth
----268.42%
Forward PE
----20.80
Free Cash Flow
---16.93M32.50M
No. Analysts
----10
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High346.0M
Avg345.2M
Low344.4M

Revenue Growth

Revenue Growth202620272028
High
33.0%
Avg
32.6%
Low
32.4%

EPS Forecast

EPS202620272028
High0.64
Avg0.57
Low0.49

EPS Growth

EPS Growth202620272028
High
313.2%
Avg
268.4%
Low
216.4%